Found "Vaccines": 76 results
Sort by
Relevance

Scientists see AIDS vaccine within reach after decades

(Reuters) – At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years.But a string of failed attempts – punctuated by a 2007 trial in which a Merck vaccine appeared to make p

What criteria do decision makers in Thailand use to set priorities for vaccine introduction? (2016)

Siriporn Pooripussarakul1, Arthorn Riewpaiboon1* , David Bishai2, Charung Muangchana3 and Sripen Tantivess4 Abstract Background: There is a need to identify rational criteria and set priorities for vaccines. In Thailand, many licensed vaccines are being considering for introduction into the Ex

How can chatbots address vaccine hesitancy? A study from Asia explores

Vaccines have been a game-changer in the fight against COVID-19. Yet, vaccine hesitancy has impeded its uptake, impacting public health efforts. At the outset of the pandemic, people had doubts about this unfamiliar virus and subsequently, the vaccine: misinformation, rumours, and doubts about COVID

Exploring Vaccine Implementation for Gavi Graduating Countries: Bhutan’s Rotavirus Vaccine Economic Evaluation

Post-graduation from Gavi support in 2016, the Bhutan Health Trust Fund took up investment for vaccine provision in the country according to its mandate. The Fund also aims to “eliminate financing uncertainties for priority core components of the Primary Health Care Services out of the income genera

EQUITY AS A CORNERSTONE OF A STRONG HEALTH SYSTEM: LESSONS FROM THE COVID-19 PANDEMIC

As we approach the end of an unprecedented year, the approval of select COVID-19 vaccines by stringent regulatory authorities and programmatic roll-out has been cause for optimism. However, it is imperative to assure equitable access to those in need in all regions of the world as a core component o

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Summary The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 20

Stepping up the campaign Against cervical cancer

The debate over the price of the vaccine against HPV has become intense When it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Huma

The debate over the price of the vaccine against HPV has become intense

The debate over the price of the vaccine against HPV has become intenseWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Human

Bridging gaps in vaccinology: Enhancing capacity for effective vaccine distribution in Indonesia and other LMICs

The COVID-19 pandemic exposed vulnerabilities within national health systems, including in vaccine delivery and distribution. This has underscored the vital importance of having in place effective vaccination strategies and the need to strengthen national and regional capabilities in the fi

Knowledge Translation: The Key to Turning Mathematical Models from a Black Box into a Powerful Tool for Policy Decision-Making (Part 1) — How Mathematical Modeling Supports Public Health—and Why It’s Not Enough

This article is part 1 of the blog series: “Knowledge Translation: The Key to Turning Mathematical Models from a Black Box into a Powerful Tool for Policy Decision-Making” As health systems become more complex, decision-makers need tools that can help them evaluate long-term outcomes and choose
10 / Page